ImClone supply deal with Lonza

Lonza Biologics (Portsmouth, N.H.), a subsidiary of Lonza Group (Zurich, Switzerland), will manufacture IMCL's IMC-C225 monoclonal antibody against the epidermal growth factor receptor (EGFr). IMCL al...